460 related articles for article (PubMed ID: 21106618)
1. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial.
Barrowclough C; Haddock G; Wykes T; Beardmore R; Conrod P; Craig T; Davies L; Dunn G; Eisner E; Lewis S; Moring J; Steel C; Tarrier N
BMJ; 2010 Nov; 341():c6325. PubMed ID: 21106618
[TBL] [Abstract][Full Text] [Related]
2. Psychosocial interventions for people with both severe mental illness and substance misuse.
Hunt GE; Siegfried N; Morley K; Sitharthan T; Cleary M
Cochrane Database Syst Rev; 2013 Oct; (10):CD001088. PubMed ID: 24092525
[TBL] [Abstract][Full Text] [Related]
3. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.
Johnson S; Rains LS; Marwaha S; Strang J; Craig T; Weaver T; McCrone P; King M; Fowler D; Pilling S; Marston L; Omar RZ; Craig M; Spencer J; Hinton M
Health Technol Assess; 2019 Aug; 23(45):1-108. PubMed ID: 31460865
[TBL] [Abstract][Full Text] [Related]
4. Early intervention for psychosis.
Marshall M; Rathbone J
Cochrane Database Syst Rev; 2006 Oct; (4):CD004718. PubMed ID: 17054213
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
[TBL] [Abstract][Full Text] [Related]
6. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
[TBL] [Abstract][Full Text] [Related]
7. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial interventions for people with both severe mental illness and substance misuse.
Cleary M; Hunt G; Matheson S; Siegfried N; Walter G
Cochrane Database Syst Rev; 2008 Jan; (1):CD001088. PubMed ID: 18253984
[TBL] [Abstract][Full Text] [Related]
9. A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial.
Graham HL; Birchwood M; Griffith E; Freemantle N; McCrone P; Stefanidou CA; Walsh K; Clarke L; Rana A; Copello A
Trials; 2014 Aug; 15():308. PubMed ID: 25085539
[TBL] [Abstract][Full Text] [Related]
10. [State-dependent motivational interviewing for people with schizophrenia and substance use: results of a randomised controlled trial].
Bechdolf A; Pohlmann B; Güttgemanns J; Geyer C; Lindner K; Ferber C; Gouzoulis-Mayfrank E
Nervenarzt; 2012 Jul; 83(7):888-96. PubMed ID: 21720841
[TBL] [Abstract][Full Text] [Related]
11. Therapist-client relationships in a psychological therapy trial for psychosis and substance misuse.
Berry K; Gregg L; Hartwell R; Haddock G; Fitzsimmons M; Barrowclough C
Drug Alcohol Depend; 2015 Jul; 152():170-6. PubMed ID: 25962788
[TBL] [Abstract][Full Text] [Related]
12. Youth social behaviour and network therapy (Y-SBNT): adaptation of a family and social network intervention for young people who misuse alcohol and drugs - a randomised controlled feasibility trial.
Watson J; Toner P; Day E; Back D; Brady LM; Fairhurst C; Renwick C; Templeton L; Akhtar S; Lloyd C; Li J; Cocks K; Ambegaokar S; Parrott S; McArdle P; Gilvarry E; Copello A
Health Technol Assess; 2017 Mar; 21(15):1-260. PubMed ID: 28399988
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.
Morrison AP; Law H; Carter L; Sellers R; Emsley R; Pyle M; French P; Shiers D; Yung AR; Murphy EK; Holden N; Steele A; Bowe SE; Palmier-Claus J; Brooks V; Byrne R; Davies L; Haddad PM
Lancet Psychiatry; 2018 May; 5(5):411-423. PubMed ID: 29605187
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis.
Berry K; Gregg L; Lobban F; Barrowclough C
Compr Psychiatry; 2016 May; 67():73-80. PubMed ID: 27095338
[TBL] [Abstract][Full Text] [Related]
15. Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial.
Haddock G; Barrowclough C; Tarrier N; Moring J; O'Brien R; Schofield N; Quinn J; Palmer S; Davies L; Lowens I; McGovern J; Lewis S
Br J Psychiatry; 2003 Nov; 183():418-26. PubMed ID: 14594917
[TBL] [Abstract][Full Text] [Related]
16. Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial.
Baker A; Bucci S; Lewin TJ; Kay-Lambkin F; Constable PM; Carr VJ
Br J Psychiatry; 2006 May; 188():439-48. PubMed ID: 16648530
[TBL] [Abstract][Full Text] [Related]
17. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.
Barrowclough C; Haddock G; Tarrier N; Lewis SW; Moring J; O'Brien R; Schofield N; McGovern J
Am J Psychiatry; 2001 Oct; 158(10):1706-13. PubMed ID: 11579006
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
